Press release
Gastroparesis Drugs Market Size 2024: Top Leaders, Report Analysis and Forecast 2032
IMARC Group, a leading market research company, has recently releases report titled "Gastroparesis Drugs Market Report by Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others), Drug Class (Prokinetic Agents, Antiemetic Agents, Botulinum Toxin Injections), Distribution Channel (Hospitals and Clinics, Pharmacies, Online Stores), and Region 2024-2032." The study provides a detailed analysis of the industry, including the global gastroparesis drugs market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the gastroparesis drugs market?
The global gastroparesis drugs market size reached US$ 6.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032.
Request for a PDF sample of this report: https://www.imarcgroup.com/gastroparesis-drugs-market/requestsample
What is Gastroparesis Drugs?
Gastroparesis, or partial paralysis, is a medical disorder wherein the natural and spontaneous stomach motility and muscles are negatively impacted, and it disrupts the digestive process. If it is not treated, then causes nausea, vomiting, stomach discomfort, and problems with blood sugar regulation and nutrient absorption. Currently, it can be medicated by using multiple gastroparesis drugs, including domperidone, Metoclopramide, Reglan, erythromycin, diphenhydramine, antiemetics, ondansetron, and prochlorperazine. These medications improve spasms in stomach muscles, enhance gastric emptying, and promote nutrition absorption; thus, gastroparesis drugs are recommended or prescribed by doctors to treat diabetes and other diseases.
What are the growth prospects and trends in the gastroparesis drugs industry?
The increasing prevalence of idiopathic gastroparesis, diabetes mellitus, and post-surgical gastroparesis is primarily driving the market growth. Moreover, the introduction of innovative drugs and treatments for avoiding symptoms such as nausea, abdominal pain, and vomiting is favoring the gastroparesis drug market. Furthermore, the significant rise in the geriatric population who are susceptible to gastroparesis due to sedentary lifestyles, extensive smoking, and consumption of alcoholic drinks are supplementing the product demand.
Moreover, the extensive investments by governments in research and development (R&D) activities to employ user-friendly approaches to formulate effective drugs for gastroparesis, is favoring the market growth. Other factors, such as the significant enhancements in the healthcare infrastructure, favorable reimbursement policies by regulatory bodies, and the growing consumer awareness regarding the availability of gastroparesis drugs on diverse shopping platforms, are contributing to the market growth.
Who are the key players operating in the industry?
The report covers the major market players including:
Abbott Laboratories
Abbvie Inc
AstraZeneca Plc
Bausch Health Companies Inc
Becton Dickinson and Company
Boston Scientific Corporation
Evoke Pharma
Medtronic plc
Neurogastrx Inc.
Sanofi S.A
Takeda Pharmaceutical Company Limited
Theravance Biopharma
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Disease Type:
Diabetic Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Others
Breakup by Drug Class:
Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injections
Breakup by Distribution Channel:
Hospitals and Clinics
Pharmacies
Online Stores
Breakup by Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4608&flag=E
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Media Contact:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Report Highlights
How big is the gastroparesis drugs market?
The global gastroparesis drugs market size reached US$ 6.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032.
Request for a PDF sample of this report: https://www.imarcgroup.com/gastroparesis-drugs-market/requestsample
What is Gastroparesis Drugs?
Gastroparesis, or partial paralysis, is a medical disorder wherein the natural and spontaneous stomach motility and muscles are negatively impacted, and it disrupts the digestive process. If it is not treated, then causes nausea, vomiting, stomach discomfort, and problems with blood sugar regulation and nutrient absorption. Currently, it can be medicated by using multiple gastroparesis drugs, including domperidone, Metoclopramide, Reglan, erythromycin, diphenhydramine, antiemetics, ondansetron, and prochlorperazine. These medications improve spasms in stomach muscles, enhance gastric emptying, and promote nutrition absorption; thus, gastroparesis drugs are recommended or prescribed by doctors to treat diabetes and other diseases.
What are the growth prospects and trends in the gastroparesis drugs industry?
The increasing prevalence of idiopathic gastroparesis, diabetes mellitus, and post-surgical gastroparesis is primarily driving the market growth. Moreover, the introduction of innovative drugs and treatments for avoiding symptoms such as nausea, abdominal pain, and vomiting is favoring the gastroparesis drug market. Furthermore, the significant rise in the geriatric population who are susceptible to gastroparesis due to sedentary lifestyles, extensive smoking, and consumption of alcoholic drinks are supplementing the product demand.
Moreover, the extensive investments by governments in research and development (R&D) activities to employ user-friendly approaches to formulate effective drugs for gastroparesis, is favoring the market growth. Other factors, such as the significant enhancements in the healthcare infrastructure, favorable reimbursement policies by regulatory bodies, and the growing consumer awareness regarding the availability of gastroparesis drugs on diverse shopping platforms, are contributing to the market growth.
Who are the key players operating in the industry?
The report covers the major market players including:
Abbott Laboratories
Abbvie Inc
AstraZeneca Plc
Bausch Health Companies Inc
Becton Dickinson and Company
Boston Scientific Corporation
Evoke Pharma
Medtronic plc
Neurogastrx Inc.
Sanofi S.A
Takeda Pharmaceutical Company Limited
Theravance Biopharma
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Disease Type:
Diabetic Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Others
Breakup by Drug Class:
Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injections
Breakup by Distribution Channel:
Hospitals and Clinics
Pharmacies
Online Stores
Breakup by Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4608&flag=E
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Media Contact:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
